谷歌浏览器插件
订阅小程序
在清言上使用

P1008 Subcutaneous Infliximab in IBD Patients Previously Treated with an Optimized Intravenous Infliximab Dosing Schedule: Preliminary Results on Expectations and Satisfaction of Switching from Intravenous to Subcutaneous Infliximab

Journal of Crohn's and Colitis(2025)

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要